Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02561403 · ClinicalTrials.gov registry record · NA

Brain Aging in Veterans (BRAVE) Training: A Cognitive Training Pilot Trial in Older Veterans With Traumatic Brain Injury

A NA study of TBI (Traumatic Brain Injury), sponsored by San Francisco Veterans Affairs Medical Center.

Completed
Registry status
NA
Development phase
89
Enrollment target
2
Study locations

NCT02561403: Completed NA study of TBI (Traumatic Brain Injury), sponsored by San Francisco Veterans Affairs Medical Center.

NCT02561403 is a NA study of TBI (Traumatic Brain Injury) that has completed, run by San Francisco Veterans Affairs Medical Center. The registered enrollment target is 89 participants, below the 169-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (47% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02561403, a NA study of TBI (Traumatic Brain Injury), has completed, sponsored by San Francisco Veterans Affairs Medical Center.

COMPLETED
Registry status
NA
Development phase
89 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to conduct a pilot trial investigating cognitive training in older Veterans with a history of traumatic brain injury (TBI) to assess training effects, acceptability of training to participants, and to explore whether other factors influence training effects.

Interventions

  • BEHAVIORAL EVO multitask video game
  • BEHAVIORAL EVO words video game

Study Locations (2)

California

  • San Francisco VA Medical Center - San Francisco
  • Veterans Home of California - Yountville

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2016-03
Est. Completion 2019-01
Phase NA

What the finished NCT02561403 record still lists

NCT02561403 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 169-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (47% lower).

The record links to 1 condition, with TBI (Traumatic Brain Injury) appearing as the primary indexed condition, and to 2 interventions - of which EVO multitask video game is the first listed.

NCT02561403 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02561403 about?

NCT02561403 is a clinical study titled "Brain Aging in Veterans (BRAVE) Training: A Cognitive Training Pilot Trial in Older Veterans With Traumatic Brain Injury". The purpose of this study is to conduct a pilot trial investigating cognitive training in older Veterans with a history of traumatic brain injury (TBI) to assess training effects, acceptability of training to participants, and to explore whether other factors influence training effects.

What is the current status of trial NCT02561403?

This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2016-03. Estimated completion is 2019-01.

What conditions does trial NCT02561403 study?

This clinical trial studies the following conditions: TBI (Traumatic Brain Injury).

What interventions are being tested in trial NCT02561403?

The interventions under investigation include: EVO multitask video game (BEHAVIORAL), EVO words video game (BEHAVIORAL).

Who is sponsoring clinical trial NCT02561403?

This trial is sponsored by San Francisco Veterans Affairs Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02561403 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for TBI (Traumatic Brain Injury)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02561403's enrollment target sits among peer trials

89 11th of 20 higher than 10 of 20 other TBI (Traumatic Brain Injury) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other TBI (Traumatic Brain Injury) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03682289 · 89 participants · Phase 2

    Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

  • NCT04787939 · 89 participants · NA

    Early Feeding After Oral Cavity Reconstruction

  • NCT05480449 · 89 participants · Phase 1

    Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

  • NCT05604131 · 89 participants · Phase 2

    Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02561403, the US trial registry maintained by the National Library of Medicine. NCT02561403 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.